UA96277U - The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
- Google Patents
The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тетяна Ярославівна БондаренкоfiledCriticalТетяна Ярославівна Бондаренко
Priority to UAU201409159UpriorityCriticalpatent/UA96277U/en
Publication of UA96277UpublicationCriticalpatent/UA96277U/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis, consisting of general clinical investigation. Additionally, determine the content of collagen type IV in bronchoalveolar fluid and with his index 165,42 ± 7,66 ng / ml and above peribronhialnoy diagnosed preconditions for the development and perivascular pneumosclerosis.
UAU201409159U2014-08-142014-08-14The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
UA96277U
(en)
The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis